Feedback / Questions
lirentelimab (AK002) - Allakos
Tezspire (tezepelumab-ekko) - AstraZeneca, Amgen
http://www.ncbi.nlm.nih.gov/pubmed/36723646
Feb 2, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next